PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-16

  1. 1,059 Posts.
    lightbulb Created with Sketch. 269
    It works!! But we already knew that..

    Where's CTX11 ?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.